| Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798) |
|---|
| 02/01/2000 | US6020349 Constrained somatostatin agonists and antagonists |
| 02/01/2000 | US6020346 Piperidine derivatives having tachykinin antagonist activity |
| 02/01/2000 | US6020335 (N-(pyridinylmethyl)-heterocyclic)ylideneamine compounds as nicotinic acetylcholine receptor binding agents |
| 02/01/2000 | US6020330 Hypolipidemic 1,4-benzothiazepine-1,1-dioxides |
| 02/01/2000 | US6020193 Recombinant C-proteinase and processes, methods and uses thereof |
| 02/01/2000 | US6020167 Composition used as a therapeutic agent against chronic viral hepatic diseases |
| 02/01/2000 | US6020161 PIGR-1, a member of immunoglobulin gene superfamily |
| 01/27/2000 | WO2000004050A2 Neurotrophic growth factor |
| 01/27/2000 | WO2000004013A1 Antagonists of gonadotropin releasing hormone |
| 01/27/2000 | WO2000004010A1 Bicyclohexane derivatives |
| 01/27/2000 | WO2000003992A1 Quinoline derivatives |
| 01/27/2000 | WO2000003991A1 Quinoline derivatives |
| 01/27/2000 | CA2338054A1 Bicyclohexane derivatives |
| 01/27/2000 | CA2337407A1 Antagonists of gonadotropin releasing hormone |
| 01/27/2000 | CA2333910A1 Neurotrophic growth factor |
| 01/26/2000 | EP0974344A2 Composition and pharmaceutical dosage form for colonic drug delivery using polysaccharides |
| 01/26/2000 | EP0973942A2 Screening method for proline-rich proteins |
| 01/26/2000 | EP0973890A2 Secreted proteins and polynucleotides encoding them |
| 01/26/2000 | EP0973819A1 Non-antigenic branched polymer conjugates |
| 01/26/2000 | EP0973799A1 Cytomodulating lipophilic peptides for modulating immune system activity and inhibiting inflammation |
| 01/26/2000 | EP0973789A1 Novel phosphate compounds and their use as medicaments |
| 01/26/2000 | EP0973748A1 Metalloproteinase inhibitors, pharmaceutical compositions containing them and their pharmaceutical uses |
| 01/26/2000 | EP0973733A1 Bis-sulfonomides hydroxamic acids as mmp inhibitors |
| 01/26/2000 | EP0973730A1 Calcilytic compounds |
| 01/26/2000 | EP0973525A1 Oral compositions containing fluocinonide |
| 01/26/2000 | EP0973512A1 N-hydroxy-2-(alkyl, aryl or heteroaryl sulfanyl, sulfinyl or sulfonyl)-3-substituted alkyl, aryl or heteroarylamides as matrix metalloproteinase inhibitors |
| 01/26/2000 | EP0973392A1 Sulfonyl divalent aryl or heteroaryl hydroxamic acid compounds |
| 01/26/2000 | EP0973390A1 Retinoid related molecules for the inhibition of endothelin-1 overproduction in disease |
| 01/26/2000 | EP0927030A4 Use of aryl n-substituted carboxamides to kill tumors |
| 01/26/2000 | EP0835251B1 Process for the production of lipoic acid |
| 01/26/2000 | EP0778834B1 Diaryl bicyclic heterocycles as inhibitors of cyclooxygenase-2 |
| 01/26/2000 | CN1242802A Notch protein and their ligands |
| 01/26/2000 | CN1242703A Chewing gum contg. colloidal bismuth subcitrate |
| 01/26/2000 | CN1242237A Dietetic food composition and dietetic method using such composition |
| 01/26/2000 | CN1242229A Navel plaster for treating stomach diseases |
| 01/26/2000 | CN1242225A Tibetan pill for treating cholecystitis and gallstones, and method for preparing same |
| 01/26/2000 | CN1242214A Traditional Chinese medicine for treating gastropathy |
| 01/26/2000 | CN1242203A Pure traditional Chinese medicine concentrated capsule for treating hepatitis B |
| 01/26/2000 | CN1048729C Novel process for prepn. of anti-ulcer agent |
| 01/26/2000 | CN1048727C Process for prepn. of 2-(1-azabicyclo (2,2,2) oct-3-yl)-2,4,5,6-tetrahydro-1H-benz |
| 01/25/2000 | US6017946 Serotonin containing formulation for oral administration and method of use |
| 01/25/2000 | US6017937 Pyridine derivative, anti-ulcer drug, and antibacterial drug |
| 01/25/2000 | US6017927 Quinuclidine derivatives and medicinal composition thereof |
| 01/25/2000 | US6017889 Metalloproteinase inhibitors |
| 01/25/2000 | US6017884 Method for treating acute hepatic failure |
| 01/25/2000 | US6017515 Using a gel or paste which comprise a group 1a or 2a compound, the anion being, e.g., a chlorite, percarbonate or perborate; cosmetics; antiulcer agents (mouth); injuries; toothpaste; bandages |
| 01/25/2000 | CA2001436C Carboxylic acid derivatives |
| 01/20/2000 | WO2000003001A1 Liver stem cell |
| 01/20/2000 | WO2000002904A1 Matrix metalloproteinase inhibitors containing aminomalonic acid derivatives and peptide backbone modified derivatives thereof |
| 01/20/2000 | WO2000002876A1 Improved process of synthesis of 5-methoxy- 2-[(4-methoxy- 3,5-dimethyl- 2-pyridyl)methyl]sulfinyl-1h-benzimidazole |
| 01/20/2000 | WO2000002870A1 Antiviral macrocyclic compounds |
| 01/20/2000 | WO2000002865A1 Pharmaceutical agents |
| 01/20/2000 | WO2000002859A1 N-substituted naphthalene carboxamides as neurokinin-receptor antagonists |
| 01/20/2000 | WO2000002851A1 Sulfur substituted sulfonylaminocarboxylic acid n-arylamides, their preparation, their use and pharmaceutical preparations comprising them |
| 01/20/2000 | WO2000002850A2 Sulfonylamino carboxylic acid n-arylamides as guanylate cyclase activators |
| 01/20/2000 | WO2000002839A1 Cytokine production and tyrosine kinase inhibitors |
| 01/20/2000 | WO2000002582A2 Treatment of celiac disease with interleukin-15 antagonists |
| 01/20/2000 | WO2000002579A2 Component b as angiogenic agent in combination with human growth factors |
| 01/20/2000 | WO2000002558A1 Use of prenyltransferase inhibitors for preparing a medicine for treating pathologies resulting from heterotrimeric g protein membrane fixation |
| 01/20/2000 | WO2000002554A1 Vitamin e and esters thereof for use in the topical treatment of mucosal pathologies |
| 01/20/2000 | WO2000002548A2 Inhibitors of proteasomal activity for stimulating bone and hair growth |
| 01/20/2000 | WO1999059526A3 Protease inhibitors |
| 01/20/2000 | CA2337795A1 Pharmaceutical agents |
| 01/20/2000 | CA2337261A1 Use of prenyltransferase inhibitors for preparing a medicine for treating pathologies resulting from heterotrimeric g protein membrane fixation |
| 01/20/2000 | CA2336990A1 Vitamin e and esters thereof for use in the topical treatment of mucosal pathologies |
| 01/20/2000 | CA2336958A1 Liver stem cell |
| 01/20/2000 | CA2336806A1 N-substituted naphthalene carboxamides as neurokinin-receptor antagonists |
| 01/20/2000 | CA2333923A1 Treatment of celiac disease with interleukin-15 antagonists |
| 01/19/2000 | EP0972773A1 2-Oxadiazolyl- or 2-thiadiazolyl-phenylcarbamate and -phenylurea derivatives, their preparation and their use as intermediates |
| 01/19/2000 | EP0972048A1 Recombinant proteins of a pakistani strain of hepatitis e and their use in diagnostic methods and vaccines |
| 01/19/2000 | EP0972021A1 Extracellular/epidermal growth factor like protein |
| 01/19/2000 | EP0971955A1 Secreted proteins |
| 01/19/2000 | EP0971950A2 Secreted proteins and polynucleotides encoding them |
| 01/19/2000 | EP0971929A1 2,3-DIHYDROFURO 3,2-$i(b)]PYRIDIN, PREPARATION AND APPLICATION THEREOF IN THERAPY |
| 01/19/2000 | EP0971920A1 Compounds for inhibition of gastric acid secretion |
| 01/19/2000 | EP0971917A1 Thiazolidinedione and oxazolidinedione derivatives having antidiabetic, hypolipidaemic and antihypertensive properties |
| 01/19/2000 | EP0971909A1 Lta 4? hydrolase inhibitors |
| 01/19/2000 | EP0971908A1 Il-8 receptor antagonists |
| 01/19/2000 | EP0971895A1 Hydroxamic acids substituted by heterocycles useful for inhibition of tumor necrosis factor |
| 01/19/2000 | EP0971894A1 Nicotinamide derivatives |
| 01/19/2000 | EP0971735A1 Methods and compositions for treating inflammatory bowel disease |
| 01/19/2000 | EP0971730A2 Assay for ligands to tyrosine kinase receptors |
| 01/19/2000 | EP0728144B1 Peptidyl compounds and their therapeutic use as inhibitors of metalloproteinases |
| 01/19/2000 | EP0625989B1 Dna sequences encoding novel growth/differentiation factors |
| 01/19/2000 | CN1242006A Guanidinyl heterocycle compounds useful as alpha-2 adrenoceptor agonists |
| 01/19/2000 | CN1242001A Guanidinylamino heterocycle compounds useful as alpha-2 adrenoceptor agonists |
| 01/19/2000 | CN1241433A Lushiyuyan capsule for treating hepatosis and its preparation |
| 01/19/2000 | CN1048492C Quinuclidine derivatives and its preparation |
| 01/19/2000 | CN1048484C A process for preparing a composition containing benzoheterocycles |
| 01/18/2000 | US6015913 Heating cocoa beans to loosen shell without roasting nib, winnowing nibs from shells, screw pressing nibs to produce cocoa butter and partially defatted cocoa solids |
| 01/18/2000 | US6015912 Treating arthritis, cancer, cardiovascular disorders, skin disorders, ocular disorders, inflammation, gum disease |
| 01/18/2000 | US6015831 Thiophene nitrone compounds |
| 01/18/2000 | US6015822 Antiulcer, antidiarrhea, and antiarrhythmia agents; cardiovascular and gastrointestinal disorders |
| 01/18/2000 | US6015818 Quinoline derivatives as bradykinin agonists |
| 01/18/2000 | US6015578 Trapidil for use in the therapy of syndrome that may be influenced by immunomodulators |
| 01/17/2000 | CA2278033A1 Pet breath ameliorator |
| 01/13/2000 | WO2000001851A1 Antisense oligonucleotides targeted to il-15 |
| 01/13/2000 | WO2000001696A1 3-ALKYLPYRROLO[3,2-c]QUINOLINE DERIVATIVES |
| 01/13/2000 | WO2000001690A1 Cinnamic acid derivatives as cell adhesion molecules |
| 01/13/2000 | WO2000001687A1 Benzothiepines having activity as inhibitors of ileal bile acid transport and taurocholate uptake |